Both in Biotechnology
Moderna vs Kymera Therapeutics
Over the past year MRNA returned +987.9% and KYMR returned +127.4%; their daily moves had a correlation of 0.21.
MRNA +987.9% KYMR +127.4%Growth of $1, one year, split-adjusted
| Metric | MRNA | KYMR |
|---|---|---|
| Price | $258.38 | $136.25 |
| Market cap | $103.15B | $11.63B |
| Today | +13.11% | +7.21% |
| 1 month | +37.8% | +28.6% |
| 6 months | +429.6% | +58.0% |
| Year to date | +776.2% | +75.1% |
| 1 year | +937.3% | +128.1% |
| Revenue growth (YoY) | +2.1% | −100.0% |
| Gross margin | 35.9% | — |
| Net margin | −539.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 46.3× | 113.8× |
| Net cash | $4.54B | $969.2M |
| Dividend yield | — | — |
| Volatility (60d) | 231.0% | 41.2% |
| Short % of float | 9.0% | 13.7% |
| Next earnings | Nov 6, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).